Article

ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune…

medRxiv · 2023 · Wee, Y.; Wang, J.; Wilson, E. C.; Rich, C. P.; Rogers, A.; Tong, Z.; DeGroot, E.; Gopal, Y. N. V.; Davies, M. A.; Ekiz, H. A.; Tay, J. K. H.; Stubben, C.; Boucher, K. M.; Oviedo, J. M.; Fairfax, K.; Williams, M. A.; Holmen, S. L.; Wolff, R.; Grossmann, A. H.

Key facts

Title ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.
First author Wee, Y.; Wang, J.; Wilson, E. C.; Rich, C. P.; Rogers, A.; Tong, Z.; DeGroot, E.; Gopal, Y. N. V.; Davies, M. A.; Ekiz, H. A.; Tay, J. K. H.; Stubben, C.; Boucher, K. M.; Oviedo, J. M.; Fairfax, K.; Williams, M. A.; Holmen, S. L.; Wolff, R.; Grossmann, A. H.
Journal medRxiv
Published Oct 2, 2023
DOI 10.1101/2023.09.29.560199
Devices mentioned K190495
Product codes mentioned DDG, JJH, MVU, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature